Frontlight ResearchEarly access
Trial site
Hong Kong United Oncology Centre
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Arcus Biosciences, Inc.1 trial
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- Relay Therapeutics, Inc.1 trial
- Revolution Medicines, Inc.1 trial
Running trials
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026